NCT04854993View on ClinicalTrials.gov

Recovery From dNMB Using Different Sugammadex Doses in Elderly Patients Undergoing Robot-assisted Prostatectomy

PHASE3CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 13, 2021

Primary Completion Date

September 20, 2022

Study Completion Date

September 23, 2022

Conditions
Prostate CancerNeuromuscular Blockade
Interventions
DRUG

Sugammadex 6 mg/kg

i.v. injection of an increased (by 50%) dose of sugammadex to reverse dNMB

DRUG

Sugammadex 4 mg/kg

i.v. injection of a standard dose of sugammadex to reverse dNMB

Trial Locations (1)

00168

Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER